Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:383426rdf:typepubmed:Citationlld:pubmed
pubmed-article:383426lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:383426lifeskim:mentionsumls-concept:C0010042lld:lifeskim
pubmed-article:383426lifeskim:mentionsumls-concept:C0392360lld:lifeskim
pubmed-article:383426lifeskim:mentionsumls-concept:C0443288lld:lifeskim
pubmed-article:383426lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:383426lifeskim:mentionsumls-concept:C0725066lld:lifeskim
pubmed-article:383426pubmed:issue2lld:pubmed
pubmed-article:383426pubmed:dateCreated1979-11-21lld:pubmed
pubmed-article:383426pubmed:abstractText54 corneas, 49 high risk cases and 5 low risk cases, were grafted with HLA-matched donor material. The importance of antigen compatibility especially in high risk cases is demonstrated. The percentage of irreversible rejections and reversible rejections in this group is markedly smaller as compared with our own "at random" material and the "at random" material of other authors. The follow-up period is 3--21 months.lld:pubmed
pubmed-article:383426pubmed:languageenglld:pubmed
pubmed-article:383426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:383426pubmed:citationSubsetIMlld:pubmed
pubmed-article:383426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:383426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:383426pubmed:statusMEDLINElld:pubmed
pubmed-article:383426pubmed:monthMarlld:pubmed
pubmed-article:383426pubmed:issn0012-4486lld:pubmed
pubmed-article:383426pubmed:authorpubmed-author:Völker-Dieben...lld:pubmed
pubmed-article:383426pubmed:authorpubmed-author:Kok-van...lld:pubmed
pubmed-article:383426pubmed:authorpubmed-author:KruitP JPJlld:pubmed
pubmed-article:383426pubmed:issnTypePrintlld:pubmed
pubmed-article:383426pubmed:day15lld:pubmed
pubmed-article:383426pubmed:volume46lld:pubmed
pubmed-article:383426pubmed:ownerNLMlld:pubmed
pubmed-article:383426pubmed:authorsCompleteYlld:pubmed
pubmed-article:383426pubmed:pagination219-26lld:pubmed
pubmed-article:383426pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-H...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-C...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-C...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-T...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-A...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-G...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-R...lld:pubmed
pubmed-article:383426pubmed:meshHeadingpubmed-meshheading:383426-H...lld:pubmed
pubmed-article:383426pubmed:year1979lld:pubmed
pubmed-article:383426pubmed:articleTitleAdvances and disappointments, indications and restrictions regarding HLA-matched corneal grafts in high risk cases.lld:pubmed
pubmed-article:383426pubmed:publicationTypeJournal Articlelld:pubmed